Serologic Responses to COVID-19 Vaccines in Hematological PatientsJun 23, 20221 min readSerologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid MalignanciesLesen Sie sich hier das Paper durch.
Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid MalignanciesLesen Sie sich hier das Paper durch.
Comments